Oral contraceptive and D-dimer level

Archives of Dermatology

Volumn 145, Issue 2, 2009, Pages 210-

  Kittisupamongkol, Weekitt ^a  

^a Hua Chiew Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; ORAL CONTRACEPTIVE AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

CONCENTRATION (PARAMETERS); GROUPS BY AGE; LETTER; ORAL CONTRACEPTION; PRIORITY JOURNAL; ADOLESCENT; ADULT; BLOOD; BLOOD CLOTTING DISORDER; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NOTE; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; VEIN MALFORMATION;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CONTRACEPTIVES, ORAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 60349114495     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.565     Document Type: Letter

References (3)

1. Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873-877.
2. Kluft C, Meijer P, LaGuardia KD, Fisher AC. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables. Contraception. 2008;77(2):77-83.
3. Johnson JV, Lowell J, Badger GJ, Rosing J, Tchaikovski S, Cushman M. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial. Obstet Gynecol. 2008;111(2, pt 1):278-284.